Endogenous glucagon-like peptide (GLP)-1 as alternative for GLP-1 receptor agonists: Could this work and how?

被引:10
作者
Smits, Mark M. [1 ,2 ,3 ,5 ]
Holst, Jens J. [1 ,4 ]
机构
[1] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, Copenhagen, Denmark
[2] Amsterdam Cardiovasc Sci Diabet & Metab, Amsterdam, Netherlands
[3] Amsterdam UMC locat Vrije Univ, Diabet Ctr, Dept Internal Med, Amsterdam, Netherlands
[4] Univ Copenhagen, Novo Nord Fdn Ctr Basic Metab Res, Fac Hlth & Med Sci, Copenhagen, Denmark
[5] Blegdamsvej 3B, DK-2200 Copenhagen, Denmark
关键词
diabetes; glucagon-like peptide-1; gut hormone; obesity; Y GASTRIC BYPASS; TYPE-2; DIABETES-MELLITUS; FOOD-INTAKE; INSULIN-SECRETION; GLUCOSE-TOLERANCE; SLEEVE GASTRECTOMY; BARIATRIC SURGERY; INCRETIN HORMONES; ACID-SECRETION; BODY-WEIGHT;
D O I
10.1002/dmrr.3699
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In recent years, we have witnessed the many beneficial effects of glucagon-like peptide (GLP)-1 receptor agonists, including the reduction in cardiovascular risk in patients with type 2 diabetes, and the reduction of body weight in those with obesity. Increasing evidence suggests that these agents differ considerably from endogenous GLP-1 when it comes to their routes of action, although their clinical effects appear to be the same. Given the limitations of the GLP-1 receptor agonists, could it be useful to develop agents which stimulate GLP-1 release? Here we will discuss the differences and similarities between GLP-1 receptor agonists and endogenous GLP-1, and will detail how endogenous GLP-1-when stimulated appropriately-could have clinically relevant effects.
引用
收藏
页数:17
相关论文
共 159 条
[1]   The inhibitory effects of peripheral administration of peptide YY3-36 and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway [J].
Abbott, CR ;
Monteiro, M ;
Small, CJ ;
Sajedi, A ;
Smith, KL ;
Parkinson, JRC ;
Ghatei, MA ;
Bloom, SR .
BRAIN RESEARCH, 2005, 1044 (01) :127-131
[2]   DPP-4 inhibitors [J].
Ahren, Bo .
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 21 (04) :517-533
[3]   Intraperitoneal Route of Drug Administration: Should it Be Used in Experimental Animal Studies? [J].
Al Shoyaib, Abdullah ;
Archie, Sabrina Rahman ;
Karamyan, Vardan T. .
PHARMACEUTICAL RESEARCH, 2020, 37 (01)
[4]   9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2022 [J].
American Diabetes Association Professional Practice Committee .
DIABETES CARE, 2022, 45 :S125-S143
[5]   Using a Reporter Mouse to Map Known and Novel Sites of GLP-1 Receptor Expression in Peripheral Tissues of Male Mice [J].
Andersen, Daniel B. ;
Grunddal, Kaare, V ;
Pedersen, Jens ;
Kuhre, Rune E. ;
Lund, Mari L. ;
Holst, Jens J. ;
Orskov, Cathrine .
ENDOCRINOLOGY, 2021, 162 (03)
[6]   A review of GLP-1 receptor agonists: Evolution and advancement, through the lens of randomised controlled trials [J].
Aroda, Vanita R. .
DIABETES OBESITY & METABOLISM, 2018, 20 :22-33
[7]   Rapid hepatic metabolism blunts the endocrine action of portally infused GLP-1 in male rats [J].
Aulinger, Benedikt A. ;
Perabo, Marta ;
Seeley, Randy J. ;
Parhofer, Klaus G. ;
D'Alessio, David A. .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2020, 318 (02) :E189-E197
[8]   Metformin-induced glucagon-like peptide-1 secretion contributes to the actions of metformin in type 2 diabetes [J].
Bahne, Emilie ;
Sun, Emily W. L. ;
Young, Richard L. ;
Hansen, Morten ;
Sonne, David P. ;
Hansen, Jakob S. ;
Rohde, Ulrich ;
Liou, Alice P. ;
Jackson, Margaret L. ;
de Fontgalland, Dayan ;
Rabbitt, Philippa ;
Hollington, Paul ;
Sposato, Luigi ;
Due, Steven ;
Wattchow, David A. ;
Rehfeld, Jens F. ;
Holst, Jens J. ;
Keating, Damien J. ;
Vilsboll, Tina ;
Knop, Filip K. .
JCI INSIGHT, 2018, 3 (23)
[9]   Genetic Identification of Vagal Sensory Neurons That Control Feeding [J].
Bai, Ling ;
Mesgarzadeh, Sheyda ;
Ramesh, Karthik S. ;
Huey, Erica L. ;
Liu, Yin ;
Gray, Lindsay A. ;
Aitken, Tara J. ;
Chen, Yiming ;
Beutler, Lisa R. ;
Ahn, Jamie S. ;
Madisen, Linda ;
Zeng, Hongkui ;
Krasnow, Mark A. ;
Knight, Zachary A. .
CELL, 2019, 179 (05) :1129-+
[10]   Portal GLP-1 administration in rats augments the insulin response to glucose via neuronal mechanisms [J].
Balkan, B ;
Li, X .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2000, 279 (04) :R1449-R1454